Global Biobanks Market Scope and Analysis by 2028
Global Biobanks Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 2.42 Billion |
Market Size by 2028 | US$ 3.76 Billion |
Global CAGR (2021 - 2028) | 6.5% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product and Service
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Key Market Players:
- Thermo Fisher Scientific Inc (US)
- Tecan Trading AG (Switzerland)
- QIAGEN (Netherlands)
- Hamilton Company (US)
- Avantor, Inc (US)
- Micronics Japan Co., Ltd. (Japan)
- BD (US)
- Taylor-Wharton (US)
- Brooks Automation, Inc (US)
- Biovault Family (UK)
- Promega Corporation (US)
- SciSafe Inc. (US)
Key Developments:
December 2021:
Thermo Fisher Scientific Inc acquired PPD, Inc., a leading global provider of clinical research services, for US$ 17.4 billion.August 2021:
Tecan Group completed the acquisition of US-based Paramit Corporation and its affiliates for a total purchase consideration of US$ 1.0 billion.January 2022:
QIAGEN announced new additions to the growing number of applications for QI Acuity, its ultrasensitive digital PCR platform that uses nanoplates to process samples in just two hours.July 2021:
BD acquired Tepha Inc., a leading developer and manufacturer of a proprietary resorbable polymer technology.
Report Coverage
The global biobanks market research report provides detailed insights into the market in terms of size, share, trends, and forecasts. It delivers crisp and precise know-how of drivers, restraints, opportunities, segments, and industrial landscape. The COVID-19 impact analysis is discussed with the opportunities observed in global and regional markets. A list of key market players with their respective developments in recent years has been reserved as a special mention.